As GLP-1 RAs show neuroprotective effect such as reduce infarct volume and neurological deficits in normoglycemic model against stroke without affecting blood glucose levels, they may be potential candidates for the treatment of stroke alone. The gene discussed is GCG; the disease is stroke disorder.